CoChat

Diabetic retinopathy screening model in low and middle-income countries: a scoping review

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 49 of the 90 sources its claims cite were checked for support.

Abstract

BACKGROUND: Diabetic retinopathy (DR), a leading cause of blindness in working-age adults, disproportionately affects low- and middle-income countries (LMICs). While preventable through early intervention, DR screening programs are often lacking in these resource-constrained settings. OBJECTIVE: This scoping review examines DR screening models implemented in LMICs, identifying evidence, research gaps, and potential improvement strategies. METHODS: A literature search across multiple databases identified studies on DR screening in LMICs, limited to peer-reviewed articles from the past 20 years focusing on DR screening model effectiveness or implementation. Key data (study design, screening techniques, outcomes) were extracted and synthesized narratively. RESULTS: This review synthesized 30 studies on DR screening in LMICs, mainly from India, South Africa, Pakistan, and Bangladesh. These studies explored diverse screening methods, from traditional techniques (ophthalmoscopy, funduscopy, slit lamp exams) to telemedicine and AI. Non-mydriatic fundus photography, often with AI-assisted grading, was common, as were remote grading and store-and-forward systems. Given the resource constraints in these settings, non-mydriatic methods were often preferred. Many studies optimized resources by training non-physicians for image acquisition, followed by specialist grading. The reviewed studies highlighted the effectiveness of community-based screening programs in expanding coverage and improving patient adherence. Furthermore, they demonstrated the cost-effectiveness of smartphone-based imaging devices and AI-driven systems. However, challenges remained, including limited infrastructure, inconsistent training, and follow-up difficulties. CONCLUSIONS: LMIC DR screening utilizes traditional and innovative technologies, with community-based approaches, telemedicine, and AI enhancing reach and accuracy. Transitioning from case-finding to population-based screening requires stronger diabetes surveillance and integration within primary care.

Overview

CoChat Summary

TL;DR

This scoping review synthesized 30 studies on diabetic retinopathy (DR) screening models in low- and middle-income countries (LMICs), covering traditional and innovative approaches such as community-based screening, telemedicine, and AI. It concludes that LMICs need stronger diabetes surveillance and integration of DR screening into primary care to move from opportunistic case-finding toward population-based screening.

Key findings

  • The review included 30 studies published between 2003 and 2023, mainly from India (n = 12), South Africa (n = 2), Pakistan (n = 2), and Bangladesh (n = 2). Across studies, patients included 67,235 with Type 2 diabetes, 762 with Type 1 diabetes, and 150,370 with unspecified diabetes.
  • Non-mydriatic fundus photography, often with AI-assisted grading, was common, as were remote grading and store-and-forward systems. Mydriasis was used in 17/30 studies; image acquisition was often by trained non-physician staff, while final grading was typically by ophthalmologists or retinal specialists in 22/30 studies.
  • Screening models performed strongly overall: sensitivity 73.5–95.8%, NPV 93.5–98%, specificity 64.2–99.6%, PPV 32.1–89.7%, and AUC 0.878–0.99. AI software showed sensitivity up to 95.8% (95% CI 92.9–98.7) and AUC for referable DR up to 0.97.
  • Challenges included limited infrastructure, inconsistent training, follow-up difficulties, and ungradable image rates from 0% to 37.8%. Only 5% of data came from low-income countries, with the rest from middle-income countries.

Methods

  • Scoping review following PRISMA-ScR guidance. Databases searched on April 21, 2025 included EMBASE, Google Scholar, Global Health, MEDLINE, SCOPUS, PUBMED, CINAHL, and Web of Science. Inclusion criteria were peer-reviewed English articles from the past 20 years on adults with DR in LMICs and implementation of specified screening models; commentaries, editorials, non-empirical literature, pediatric populations, and other eye diseases were excluded.
  • From 1,225 records, 298 duplicates were removed, 927 were screened, 119 full texts were assessed, and 30 studies were included. Three independent reviewers screened titles/abstracts, with a fourth reviewer resolving discrepancies.
  • Data were extracted into an Excel standardized form and synthesized descriptively/narratively, covering settings, populations, screening techniques, mydriasis, personnel, image acquisition, remote grading, AI integration, and performance metrics. Methodological quality was not appraised in detail.

Limitations

  • Stated by the authors: only 5% of data came from low-income countries, with the rest from middle-income countries, limiting global representation and generalizability; as a scoping review, it did not conduct detailed methodological quality appraisal; and low-income country infrastructure, resources, and demographics may differ significantly from middle-income settings.
  • Stated by the authors: there is a lack of comprehensive data on diabetes prevalence and screening coverage, and many LMICs lack national diabetes registries, making it unclear what proportion of people with diabetes are reached for initial or repeat screening; many DR programs therefore function as opportunistic case-finding rather than systematic screening.
  • Evident from the text: the search was confined to English-language sources and excluded grey literature, which may omit relevant local or non-English evidence; the absence of formal quality appraisal also limits confidence in the included studies’ findings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12889-025-25543-6

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Flowchart
Fig. 1 FlowchartCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

19 Valid · 1 Not valid · 5 Not checked · 25 Own results and interpretations

10 more claims

Create a free account to see all 50 claims and to verify the 14 references still open.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 10
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 49 references

Research works printed but not linked: 6

  1. International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
  2. Jani PK, Makwana HL, Patel P. Community-based screening for diabetic retinopathy using trained paramedical personnel. Indian J Ophthalmol. 2020;68(10):2200–4. https://doi.org/10.4103/0301-4738.191522. · doi:10.4103/0301-4738.191522
  3. Sharma A, Biswas P, Khokhar S, et al. Teleophthalmology as a model for detecting diabetic retinopathy in resource-poor settings. Indian J Ophthalmol. 2018;66(8):1109–12. https://doi.org/10.4103/0301-4738.232049. · doi:10.4103/0301-4738.232049
  4. Silva PS, Cavallerano JD, Aiello LM, Aiello LP. Telemedicine and diabetic retinopathy: moving forward into the new decade. Diabetes Technol Ther. 2011;13(10):1075–83.
  5. Salongcay RP, Silva PS. The role of teleophthalmology in diabetic retinopathy screening. J Clin Med. 2020;9(7):2196.
  6. Zimmer-Galler IE, Zeimer R, et al. The optos Panoramic200MA retinal imaging system: clinical effectiveness at detecting diabetic retinopathy. Eye (Lond). 2012;26(10):1427–35.

Cited by

Metadata

Authors
Lestari, Y. D., Sitompul, R., Widyahening, I. S., Tahapary, D. L., Yusuf, P. A., Sasongko, M. B., Riono, P., Nursakina, Y., & Alexandra, G.
Affiliations
  • University of Indonesia (ID)
  • Universitas Gadjah Mada (ID)
  • Imperial College London (GB)
Corresponding author
Lestari, Yeni Dwi
Venue
BMC Public Health
Published
2025-12-03
Volume
25
Issue
1
Pages
4210-4210
ISSN
1471-2458 (ISSN-L)
OpenAlex
W4416949330
Cited by
11
References
45
Citations by year
2026: 11
FWCI
1.72
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Public Health (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Universitas Indonesia (NKB-294/UN2.RST/HKP.05.00/2024)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
diabetic retinopathy, diabetic retinopathy screening, low- and middle-income countries, telemedicine, artificial intelligence, non-mydriatic fundus photography, store-and-forward, community-based screening, smartphone-based imaging, cost-effectiveness, diabetes surveillance, primary care integration, blindness prevention
MeSH terms
Developing Countries, Diabetic Retinopathy, Humans, Mass Screening, Telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetic retinopathy screening model in low and middle-income countries: a scoping review. https://app.cochat.ai/papers/10.1186/s12889-025-25543-6
The paper
Lestari, Y. D., Sitompul, R., Widyahening, I. S., Tahapary, D. L., Yusuf, P. A., Sasongko, M. B., Riono, P., Nursakina, Y., & Alexandra, G. (2025). Diabetic retinopathy screening model in low and middle-income countries: a scoping review. BMC Public Health. https://doi.org/10.1186/s12889-025-25543-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.